Stocks TelegraphStocks Telegraph
Screener NEW

NBSE Stock Price History and Quote Analysis Insights for Investors

NASDAQ : NBSE

NeuBase Therapeutics, Inc.

$0.38
-0.006-1.56%
Open: 4:00 PM
Not Actively Trading
61.87
BESG ScoreESG Rating
Loading...

Stock Price Today

NeuBase Therapeutics, Inc. (NBSE) stock declined over -1.56%, trading at $0.38 on NASDAQ, down from the previous close of $0.38. The stock opened at $0.38, fluctuating between $0.37 and $0.39 in the recent session.

Stock Snapshot

0.384
Prev. Close
0.38
Open
1.42M
Market Cap
3.75M
Number of Shares
0.365
Day Low
0.3914
Day High
-0.02032258064516129
P/E Ratio
87.99%
Free Float in %
-18.6
EPS (TTM)
3.31
Book Value
-5.38
Cash Flow per Share
89.7K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
May 17, 20240.380.380.380.380
May 10, 20240.380.390.370.3897.74K
May 09, 20240.410.410.380.3959.03K
May 08, 20240.410.410.370.4154.52K
May 07, 20240.430.430.390.4035.45K
May 06, 20240.380.420.360.41156.78K
May 03, 20240.410.420.400.41728.67K
May 02, 20240.420.430.410.4126.91K
May 01, 20240.420.420.420.421.18K
Apr 30, 20240.420.440.410.428.86K
Apr 29, 20240.420.430.410.429.87K
Apr 26, 20240.430.450.410.4472.17K
Apr 25, 20240.430.450.430.4425.64K
Apr 24, 20240.450.450.420.4221.22K
Apr 23, 20240.410.450.400.4258.43K
Apr 22, 20240.420.420.400.42157.79K
Apr 19, 20240.410.430.410.4388.89K
Apr 18, 20240.420.440.410.4347.88K
Apr 17, 20240.430.440.400.4230.89K
Apr 16, 20240.420.420.400.4068.24K

Contact Details

Pittsburgh, PA 15219

United States

Website: https://www.neubasetherapeutics.comContact: 646 450 1790

About Company

NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its lead programs include NT0100, a PATrOL enabled anti-gene for Huntington's disease; NT0200, a PATrOL enabled anti-gene for myotonic dystrophy type 1; NT0300, a PATrOL-enabled therapeutic treatment to target the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.

Company Information

Employees37
Beta0.94
Sales or Revenue$0.00
5Y Sales Change%0%
Fiscal Year EndsSeptember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current NeuBase Therapeutics, Inc. (NBSE) stock price?

NeuBase Therapeutics, Inc. (NASDAQ: NBSE) stock price is $0.38 in the last trading session. During the trading session, NBSE stock reached the peak price of $0.39 while $0.37 was the lowest point it dropped to. The percentage change in NBSE stock occurred in the recent session was -1.56% while the dollar amount for the price change in NBSE stock was -$0.01.

NBSE's industry and sector of operation?

The NASDAQ listed NBSE is part of Biotechnology industry that operates in the broader Healthcare sector. NeuBase Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NBSE?

Mr. Todd P. Branning
Chief Financial Officer & Sec.
Dr. Robert J. Zamboni Ph.D.
Chief of Preclinical Devel. & Member of Scientific Advisory Board
Dr. Dietrich A. Stephan Ph.D.
Founder, Chief Executive Officer, Pres & Director
Dr. Curt Bradshaw Ph.D.
Chief Scientific Officer
Ms. Shannon McCarthy
Chief People Officer
Dr. Ron Sarkar M.B.A., Ph.D.
Senior Vice President of Corporation Strategy & Bus. Devel.
Mr. Alan Scrivner J.D.
Gen. Counsel

How NBSE did perform over past 52-week?

NBSE's closing price is 5% higher than its 52-week low of $0.36 where as its distance from 52-week high of $4.44 is -91.49%.

How many employees does NBSE have?

Number of NBSE employees currently stands at 37.

Link for NBSE official website?

Official Website of NBSE is: https://www.neubasetherapeutics.com

How do I contact NBSE?

NBSE could be contacted at phone 646 450 1790 and can also be accessed through its website. NBSE operates from 350 Technology Drive, Pittsburgh, PA 15219, United States.

How many shares of NBSE are traded daily?

NBSE stock volume for the day was 89.7K shares. The average number of NBSE shares traded daily for last 3 months was 128.24K.

What is the market cap of NBSE currently?

The market value of NBSE currently stands at $1.42M with its latest stock price at $0.38 and 3.75M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph